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Fragile X-associated Tremor/Ataxia Syndrome:  
RNA or RAN
1. A key pathogenic event in FXTAS is the expression of a toxic polyglycine-con-
taining protein, FMRpolyG, that disrupts the neuronal nuclear lamina architec-
ture (this thesis).
2. FMRpolyG expression plays a role in the toxic gain-of-function mechanism 
underlying the medical co-morbidities in FXTAS (this thesis).
3. Mitochondrial dysfunction causes the early demise of inducible FXTAS mice 
without the presence of ubiquitin-positive inclusions (this thesis).
4. Early therapeutic intervention is essential for FXTAS patients (this thesis).
5. Small chemical compounds that shield the CGG repeat show great potential to 
ameliorate FXTAS symptoms (this thesis).
6. The molecular pathology of microsatellite disorders is more complex than is 
currently appreciated (Zu et al., PNAS, 2011).
7. Heritable human genetic modifications, including CRISPR/CAS technology, pose 
serious risks and the therapeutic benefits are tenuous (Lanphier et al., Nature, 2015).
8. Preclinical animal experiments investigating human autoimmune diseases have 
been invaluable for the discovery of key immune processes, basic disease 
mechanisms and candidate immune-targeting strategies with clinical utility 
(Roep et al., Nature Medicine, 2012).
9. Moderate coffee drinking at midlife significantly delays the onset of dementia in 
the sunset years (Cao et al., Journal of Alzheimer’s Disease, 2012).
10. A DNA-based storage system is the ultimate data storage solution (Bornholt et 
al., ASPLOS, 2016).
11. Science is a marathon, not a sprint! 
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